飛毛腿(01399.HK)委任張為國為獨立非執行董事
格隆匯5月19日丨飛毛腿(01399.HK)發佈公告,由於何鍾泰擔任非執行董事及王志榮擔任獨立非執行董事各自的任期將於2020年6月16日屆滿,且由於彼等擬專注於各自的事務,各方已一致同意不再延期,董事會已批准(i)委任現任執行董事馮明竹接替何鍾泰擔任主席,自2020年5月19日起生效;(ii)委任張為國為獨立非執行董事、提名委員會主席以及審核委員會、薪酬委員會及企業管治委員會成員,自2020年5月19日起生效;及(iii)何鍾泰繼續擔任薪酬委員會、提名委員會及企業管治委員會成員以及王志榮繼續擔任審核委員會、薪酬委員會、提名委員會及企業管治委員會成員,直至2020年6月16日(包括當日)止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.